×
About 246 results
CYRAMZA® (ramucirumab)
http://www.cyramzahcp.com/

CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).

CAPECITABINE TABLETS
https://www.accordhealthcare.us/products#capecitabine-tablets

Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.

Herceptin (trastuzumab)
https://www.herceptin.com/hcp/

Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.

OPDIVO (nivolumab) injection
http://www.opdivohcp.com/

Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.

ELEVIEW SUBMUCOSAL INJECTION
https://www.eleviewus.com/

Learn about Eleview™, a submucosal injection agent designed to lift polyps and keep them lifted during gastrointestinal endoscopic resection procedures.

INFUGEM™ - Gemcitabine In Sodium Chloride‎
http://infugem.com/

For US Healthcare Professionals. View Indications, Usage & Full Prescribing Information

LENVIMA® (lenvatinib) CAPSULES
http://www.lenvima.com/hcp/

Learn about LENVIMA (lenvatinib) clinical trial, dosing information, & patient reimbursement information. See Important Safety Information.

ONCOZENE MICROSPHERES
http://www.bostonscientific.com/en-US/products/embolization/Oncozene-Microspheres.html

Oncozene Microspheres are precisely calibrated to enhance treatment options

ONIVYDE® (irinotecan liposome injection)
https://www.onivyde.com/

ONIVYDE® (irinotecan liposome injection) in combination for patients with metastatic pancreatic cancer previously treated with gemcitabine. See Important Safety Information, including Boxed Warning.

ONTRUZANT (trastuzumab-dttb) for injection Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761100s000lbl.pdf

Ontruzant is a HER2/neu receptor antagonist indicated for: The treatment of HER2-overexpressing breast cancer. The treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Gemzar® (gemcitabine for injection)
http://pi.lilly.com/us/gemzar.pdf

Gemzar. GEMZAR (gemcitabine for injection), for intravenous use. Initial U.S. Approval: 1996 ..... http://www.osha.gov/SLTC/hazardousdrugs/index.html. 2.7.

LIPIODOL® (Ethiodized Oil) Injection
http://www.guerbet-us.com/products/lipiodol.html

Lipiodol is an oil-based radio-opaque contrast agent indicated for: selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC); hysterosalpingography in adults; lymphography in adult and pediatric patients ...

ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension)
https://www.abraxanepro.com/

Learn more about ABRAXANE®, including dosing, efficacy, and safety information. This site is intended for US healthcare professionals only.

AVASTIN® (bevacizumab)
https://www.avastin-hcp.com/

Learn about Avastin® (bevacizumab) for FDA approved indications. Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer (rOC) Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial

CHIRHOSTIM HUMAN SECRETIN FOR INJECTION
http://human-secretin.com/html/index.aspx?page=home

Secretin, Human Secretin, secretin stimulation test, SMRCP, ERCP, Gastrinoma, EUS, EPFT, MRCP, pancreas, Zollinger-Ellison Syndrome, pancreatic cancer, ChiRhoStim, chronic pancreatitis, acute pancreatitis, pancreatic exocrine dysfunction, facilitating and cannulate ERCP, pancreas divisum, gastrinoma

SUTENT® (sunitinib malate) capsules
https://www1.pfizerpro.com/product/sutent

Info for healthcare professionals on SUTENT® (sunitinib malate) for treatment of adv RCC, imatinib-resistant/intolerant GIST, and adv pNET. See risks & benefits.

XELODA® (CAPECITABINE)
https://www.gene.com/medical-professionals/medicines/xeloda

Xeloda is indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer

Tarceva® (erlotinib) mNSCLC & Pancreatic Cancer Treatment
https://www.tarceva.com/hcp/

First-line treatment for EGFR mutation-positive metastatic NSCLC with exon 19 deletions or exon 21 (L858R) substitution mutations

NEXAVAR (sorafenib) tablets
http://hcp.nexavar-us.com

Healthcare Professional site for NEXAVAR® (sorafenib). Learn more about whether NEXAVAR is appropriate for your patients.

NEXPLANON (etonogestrel implant)
https://www.merckconnect.com/nexplanon/overview.html

NEXPLANON should not be used in women who have known or suspected pregnancy; current or past history of thrombosis or thromboembolic disorders; liver tumors, benign or malignant, or active liver disease; undiagnosed abnormal genital bleeding; known or suspected breast cancer, personal history of breast cancer, ...